Washington, D.C. – Today, White House Office of National Drug Control Policy (ONDCP) Director Dr. Rahul Gupta released a statement on the implementation of the Biden-Harris Administration’s National Xylazine Response Plan. Earlier this year, Dr. Gupta used an executive authority for the first time in the nation’s history to designate fentanyl combined with xylazine as an…
Search Results
Search results for: “xylazine”
ICYMI: In Continued Response to Overdose Epidemic, the White House Releases National Response Plan to Address the Emerging Threat of Fentanyl Combined with Xylazine
Washington, D.C. – Today, the White House Office of National Drug Control Policy (ONDCP) released a National Response Plan to coordinate a whole-of-government response in the continued efforts to address the deadly combination of xylazine mixed with fentanyl. Earlier this spring, ONDCP Director Dr. Gupta used an executive designation authority to designate fentanyl combined with xylazine…
In Continued Fight Against Overdose Epidemic, the White House Releases National Response Plan to Address the Emerging Threat of Fentanyl Combined with Xylazine
Earlier this year, Biden-Harris Administration used executive designation authority for the first time to declare xylazine combined with fentanyl as an emerging threat to the United States Washington, D.C. – Today, in the continued efforts to fight the dangerous and deadly combination of xylazine mixed with fentanyl, the White House Office of National Drug Control…
FACT SHEET: In Continued Fight Against Overdose Epidemic, the White House Releases National Response Plan to Address the Emerging Threat of Fentanyl Combined with Xylazine
Earlier this year, Biden-Harris Administration used executive designation authority for the first time to declare xylazine combined with fentanyl as an emerging threat to the United States WASHINGTON, DC – Today, in the continued efforts to fight the dangerous and deadly combination of xylazine mixed with fentanyl, the White House Office of National Drug Control…
NEJM Publishes ONDCP Op-ed on the Medical and Public Health Imperatives Surrounding Xylazine, which Dr. Gupta Designated as an Emerging Drug Threat to the Nation
“Xylazine poses a threat to public health… Our goal is for the designation of xylazine as an emerging threat and subsequent actions to begin to address this threat before it worsens and undermines efforts to reduce illicit fentanyl use in the United States.” Washington, D.C. – Today, The New England Journal of Medicine published an…
Biden-Harris Administration Designates Fentanyl Combined with Xylazine as an Emerging Threat to the United States
Xylazine’s growing role in overdose deaths nationwide prompts Administration to make this designation for the first time in U.S. history ATLANTA, GA – Today, Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), has officially designated fentanyl adulterated or associated with xylazine as an emerging threat to the United…
Neera Tanden Remarks to Press on Opioids
As Prepared For Delivery: Thank you, Dr. Gupta, for your leadership on this issue of such great importance to the American people. We are so grateful for your holistic approach to tackling the opioid crisis not only at the federal level, but also at the state level in West Virginia. Thank you for everything you…
Dr. Rahul Gupta Statement on New Xylazine-Related Death Data
Washington, D.C. – Today, Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), issued the following statement regarding the CDC’s release of drug overdose death data involving illegally manufactured fentanyl (IMF) where xylazine was detected. The data show that the monthly percentage of illegally manufactured fentanyl-involved deaths with xylazine…
In Philadelphia, ONDCP Director Meets with Leaders on the Front Lines of Fentanyl and Xylazine Crisis
During his visit, Dr. Gupta visited Kensington and met with public health leaders, treatment providers, law enforcement, Commonwealth and local officials, and harm reduction leaders on the frontlines of the overdose epidemic Philadelphia, PA – Dr. Rahul Gupta, the White House Director of the Office of National Drug Control Policy (ONDCP), traveled to Philadelphia, Pennsylvania…
Readout from Dr. Gupta’s Listening Session with Public Health and Safety Leaders on Xylazine and Efforts to Address Trends
WASHINGTON, D.C. – Last week, Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), hosted a listening session with public health and public safety leaders from several states and territories about trends they are seeing related to the drug xylazine and efforts to address these trends. Xylazine, a drug used…
